| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ABT-199 | CTRPv2 | pan-cancer | AAC | 0.062 | 0.2 |
| mRNA | FQI-2 | CTRPv2 | pan-cancer | AAC | 0.045 | 0.2 |
| mRNA | pac-1 | GDSC1000 | pan-cancer | AAC | -0.047 | 0.2 |
| mRNA | pac-1 | CTRPv2 | pan-cancer | AAC | 0.05 | 0.2 |
| mRNA | SL 0101-1 | GDSC1000 | pan-cancer | AAC | 0.047 | 0.2 |
| mRNA | KU-55933 | GDSC1000 | pan-cancer | AAC | 0.046 | 0.2 |
| mRNA | SID 26681509 | CTRPv2 | pan-cancer | AAC | 0.052 | 0.2 |
| mRNA | decitabine:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.044 | 0.2 |
| mRNA | AMG-706 | GDSC1000 | pan-cancer | AAC | 0.045 | 0.2 |
| mRNA | AZD6482 | CTRPv2 | pan-cancer | AAC | -0.051 | 0.2 |